Viewing Study NCT00184938



Ignite Creation Date: 2024-05-05 @ 11:56 AM
Last Modification Date: 2024-10-26 @ 9:17 AM
Study NCT ID: NCT00184938
Status: SUSPENDED
Last Update Posted: 2008-03-28
First Post: 2005-09-12

Brief Title: Opioid Receptors Influence Ischemia-Reperfusion Injury
Sponsor: Radboud University Medical Center
Organization: Radboud University Medical Center

Study Overview

Official Title: Opioid Induced Acute Preconditioning
Status: SUSPENDED
Status Verified Date: 2008-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The most powerful protective mechanism against ischemia-reperfusion injury other than rapid reperfusion is ischemic preconditioning Ischemic preconditioning is defined as the development of tolerance to ischemia-reperfusion injury by a previous short bout of ischemia resulting in a marked reduction in infarct size This mechanism can be mimicked by several pharmacological substances such as adenosine and morphine

We the researchers at Radboud University Nijmegen Medical Centre have recently developed a method in which we can detect ischemia-reperfusion injury in the human forearm by using Annexin A5 scintigraphy Rongen et al With this method we will determine whether opioid receptors are involved in ischemic preconditioning We expect to find that morphine can mimic ischemic preconditioning and that acute ischemic preconditioning can be blocked with the opioid receptor antagonist naloxon This study will increase our knowledge about the mechanism of ischemic preconditioning and may also provide leads to exploit this endogenous protective mechanism in a clinical setting
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None